Citations

Mayo Clinic

Clear

7550 citation(s) found for "Ku, Matthew".

A translational platform for brain-computer interfaces and adaptive neuromodulation: Technical characterization, long-term validation, and implementation of the CorTec brain interchange-BCI2000 ecosystem
Lampert, Frederik , Baker, Matthew R , Engelhardt, William , Gkogkidis, C Alexis , Ayyoubi, Amir Hossein , Fazli Besheli, Behrang , Boom, Max van den , Kellar, Douglas J , Kim, Inyong , Staff, Nathan P , Schalk, Gerwin , Ince, Nuri Firat

Journal of Neural Engineering | November 12, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1088/1741-2552/aec198 | PMID 43019594 Get It

Abstract Objective: Adaptive neuromodulation systems and implantable brain-computer interfaces (BCIs) are promising therapies for neurological and psychiatric disorders. However, their broader translation into research and clinical practice remains limited by technological complexity, restricted access to implantable research platforms, and the lack of standardized, reproducible experimental workflows. We therefore aimed to develop and validate an open, general-purpose translational ecosystem that enables rapid development, evaluation, and dissemination of novel neuromodulation and implantable BCI paradigms.
Approach: The CorTec Brain Interchange (BIC) implantable neural sensing and stimulation device was integrated with the open-source BCI2000 platform to create a modular, extensible neuromodulation ecosystem. We established a standardized battery of quantitative assessments to characterize implantable neuromodulation systems to comprehensively evaluate the CorTec BIC device through benchtop characterization, long-term preclinical in vivo validation, and a human feasibility demonstration using the benchtop BIC system connected to externalized leads.
Results: Comprehensive benchtop characterization of the BIC device independently validated previously reported performance while extending its evaluation through quantification of recording noise, acquisition and stimulation latencies, and validation of impedance measurements. Long-term in vivo validation in five canines, with the longest implantation exceeding three years, demonstrated stable chronic recordings while also capturing progressive deterioration of individual channels through longitudinal changes in signal quality and impedance. The ecosystem enabled active functional decoding more than two years after implantation, closed-loop stimulation using arbitrary spectral biomarkers, capturing brain stimulation evoked potentials, detection of epilepsy-associated biomarkers and observational assessment of their response to stimulation. In addition, we translated an established one-dimensional BCI cursor-control paradigm to the BIC benchtop system, demonstrating ecosystem portability and feasibility with a human participant. Finally, we share surgical protocols, imaging and analysis pipelines, datasets, and software to facilitate reproducible neuromodulation research.
Significance: We present a versatile, open-source translational ecosystem that supports a wide range of neuromodulation and implantable BCI applications with minimal modification. By combining comprehensive hardware characterization with standardized software tools and experimental workflows, this work provides a practical reference for researchers adopting the BIC platform while establishing a broadly applicable framework for systematic characterization of implantable neuromodulation systems. The ecosystem lowers technical barriers to implantable neurotechnology research, promotes reproducibility, and provides a foundation for accelerating the development and clinical translation of next-generation adaptive neuromodulation and implantable BCI therapies for patients with neurological and psychiatric disorders.
Clinical phenotypes, autoimmunity and outcomes in Rosai–Dorfman disease: An international multicentre cohort study
Sen, Mitali , Ruan, Gordon J , Reynolds, Samuel , Ali, Haadi , Morlote, Diana M. , Koster, Matthew J , Abeykoon, Jithma P , Salama, Hind , Ahmed, Asra Z , Go, Ronald S , Goyal, Guarav

British Journal of Haematology | November 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1111/bjh.70939 | PMID 43014348 Get It

Summary Rosai–Dorfman disease (RDD) is a rare histiocytic neoplasm with diverse clinical behaviour and immune abnormalities with unknown clinical significance. We performed a retrospective cohort study of 162 patients with RDD from 2003 to 2025 at five international referral centres. Median age was 48 years and 64.8% were female. Multisystem disease occurred in 87 patients (53.7%), commonly involving skin/subcutaneous tissue (49.4%), lymph nodes (39.5%) and bones (34%). Molecular testing was available for 102 patients; 40 (39.2%) were mitogen‐activated protein kinase/rat sarcoma virus oncogene homolog signaling pathway (MAPK/RAS)‐altered, commonly with kirsten rat sarcoma viral oncogene homolog ( KRAS ) or mitogen‐activated protein kinase 1 ( MAP2K/MEK ) alterations. MAPK/RAS alterations were associated with multisystem disease ( p = 0.0034). Autoimmune disease (AID) was documented in 29 patients (17.9%), usually preceding RDD, and 45/95 patients (47.4%) with available autoantibody status had at least one positive autoantibody. Among 153 patients with response data, objective response occurred in 94 (61.4%). Response distribution differed by disease extent; single‐system disease was associated with more complete responses and less progression than multisystem disease. At a median follow‐up of 2.49 years, eight deaths occurred; 5‐year overall survival was 93.4%. AID and autoantibody positivity were not associated with response or overall survival. These findings support disease extent and molecular status as clinically relevant dimensions of RDD assessment, while autoimmune and serological abnormalities should be interpreted in clinical context.
Modernization of a Historical Prostate Cancer Registry using Artificial Intelligence: A Tale of Two Large Language Models
Wang, Michael , Diaz-Cabo, Julian, O'Byrne, Jamie, Gettman, Matthew T.

Journal of Urology | November 11, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/ju.0000000000005387 | PMID 43013751 Get It

The Modern Utility of Awake Deep Brain Stimulation Surgery
Baker, Matthew R

Operative Neurosurgery | November 10, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1227/ons.0000000000002230 | PMID 43007714 Get It

BACKGROUND AND OBJECTIVES: Advances in neuroimaging and stereotactic accuracy have led many centers to adopt asleep workflows for deep brain stimulation (DBS), raising questions about the continued role of awake surgery with microelectrode recording. We evaluated whether intraoperative physiological testing during awake ventral intermediate nucleus (Vim) DBS results in trajectory adjustments that converge with the imaging-defined target. METHODS: We retrospectively reviewed 137 consecutive Vim DBS leads implanted in awake patients. For each lead, we determined whether the final implant followed the planned trajectory, required a depth adjustment, or was moved to a parallel trajectory based on microelectrode recording and test stimulation. In cases involving parallel trajectory adjustments, coregistered preoperative imaging and postoperative computed tomography were used to compare the final lead position with the imaging-defined target and determine the direction and magnitude of deviation. Intraoperative ring stimulation data were analyzed to compare tremor suppression and side effects before and after trajectory adjustment. RESULTS: Of 137 leads, 116 (85%) were implanted along the planned trajectory, including 49 at the planned depth and 67 with depth adjustments. Twenty-one leads (15%) were moved to a parallel trajectory based on intraoperative findings; 17 had data suitable for spatial analysis. Among these, 13 (76%) were moved farther from the imaging-defined target, 2 (12%) an equal distance across the target, and 2 (12%) closer. In 12 cases with paired pre- and postadjustment stimulation testing, trajectory adjustment was associated with reduced stimulation required for near tremor resolution, increased side effect thresholds, and expansion of the therapeutic window. No leads required revision. CONCLUSION: Intraoperative physiological testing during awake Vim DBS frequently prompted trajectory adjustments that would not have been made under imaging guidance alone and were associated with improved stimulation response, underscoring the continuing role of awake testing in refining lead placement to patient-specific functional anatomy.
False-positive beta-2 transferrin test not associated with a postoperative lumbar cerebrospinal fluid leak: A case report
Dufault, Matthew , Dhupati, Pooja , Jeger, Jonathan L , Lettieri, Salvatore C. , Gridley, Daniel, Feiz‐Erfan, Iman

Surgical Neurology International | November 6, 2026 | Volume: 17 | Issue: No issue available | Pages: 638

10.25259/sni_1181_2026 Get It

Background: Lumbar laminectomy and fusion may be complicated by cerebrospinal fluid (CSF) leaks. Beta-2 transferrin (B2T) is a diagnostic marker for CSF that has been mostly studied in the context of cranial CSF leak, but its accuracy in diagnosing spinal leaks is less certain. Case Description: A 59-year-old male with chronic back pain and lumbar stenosis underwent a multi-level laminectomy and fusion with a watertight repair of incidental durotomy. Postoperatively, he developed a non-healing surgical wound and persistent high drain output with fluid testing positive for B2T. However, the patient had no clinical symptoms or signs of CSF leak and repeated wound exploration showed no leak. The wound became infected and, due to poor healing, the patient underwent a secondary closure with a negative pressure treatment dressing. Multiple intraoperative dressing changes did not disclose a CSF leak despite the fact that a repeat B2T in the wound fluid remained positive. Conclusions: This report describes a case of false-positive B2T in a patient after lumbar spine surgery. This case highlights the fact that a positive B2T measured in spinal wound fluid may not be diagnostic of a CSF leak. Possible sources of false-positive B2T laboratory results are discussed in this paper.
Technology Assistance and Fixed-Bearing Design Were Associated with Higher Revision-Free Survival at 15 Years After UKA
Tsukamoto, Ichiro , Grimm, Jessica A , Sierra, Rafael J , Abdel, Matthew P , Hannon, Charles P

Journal of Bone and Joint Surgery | November 5, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.2106/jbjs.26.00507 | PMID 42987190 Get It

Background: Unicompartmental knee arthroplasty (UKA) is an alternative to total knee arthroplasty for isolated compartment osteoarthritis; however, concerns persist regarding its long-term durability. The purpose of this study was to evaluate revision-free survivorship, risk factors for revision, and clinical outcomes in a large consecutive series of contemporary UKAs. Methods: We retrospectively reviewed consecutive primary UKAs performed from 2000 to 2021 at a single tertiary academic center. Revision-free survivorship was estimated using a Kaplan-Meier analysis, and risk factors for revision were assessed using Cox proportional hazards modeling. Clinical outcomes were assessed using the Knee Society Score (KSS). Results: A total of 2,234 UKAs were included. Fixed-bearing implants were used in 78% of UKAs. Technology assistance was used in 59% of UKAs (fluoroscopy, 43%; robotic assistance, 15%; computer navigation, 1%). The mean patient age was 65 years, the mean body mass index was 31 kg/m 2 , and 49% of UKAs were performed in female patients. Patient race was White in 97% of UKAs, and patient ethnicity was not Hispanic or Latino in 94%. Revision-free survivorship was 92% at 10 years and 85% at 15 years. Overall, 118 UKAs were revised, most commonly through conversion to total knee arthroplasty (97%). The most frequent indications for revision were progression of osteoarthritis in an adjacent compartment (41%), aseptic loosening (23%), unexplained pain (9%), and hardware failure (9%). Factors associated with a lower risk of revision in the univariable analysis included technology assistance (hazard ratio [HR], 0.4; p < 0.01) and high surgeon volume (HR, 0.5; p < 0.01). Mobile-bearing design (HR, 1.9; p < 0.01) was associated with an increased risk of revision in the univariable analysis. The mean KSS improved from 47 preoperatively to 75 at 5 years postoperatively (p < 0.001). Conclusions: In this large consecutive series, UKA demonstrated excellent long-term survivorship, with an approximately 1% annual risk of revision through 15 years. Technology assistance, a fixed-bearing implant design, and high surgeon volume were each associated with a lower risk of revision, underscoring the importance of operative technique and implant selection in achieving durable outcomes. Level of Evidence: Therapeutic Level III . See Instructions for Authors for a complete description of levels of evidence.
When In-Person Interpretation Matters: Perspectives From ICUs and Acute Inpatient Care Settings
Tang, Matthew, Curtis, Susan , Al-Khatib, Ahmad Z

American Journal of Critical Care | November 1, 2026 | Volume: 35 | Issue: 6 | Pages: 432-444

10.4037/ajcc2026387 | PMID 42966651 Get It

Background Clinicians often care for multilingual patients and generally prefer in-person rather than remote interpretation. However, little is known about the reasons for selecting specific interpretation modalities in intensive care units (ICUs) and acute inpatient care settings. Objective To examine the context and application of in-person interpretation in ICUs and acute care settings. Methods Semistructured interviews of interprofessional stakeholders were conducted to understand the advantages and limitations of in-person and remote interpretation modalities in ICUs and acute care settings. Thematic analysis of the interviews was performed. Results Forty-one interviews were completed. Certain contexts motivated preferences for selecting in-person rather than remote interpretation in ICUs and acute care settings. Three overarching themes were identified: (1) specific types of conversations (eg, goals-of-care, end-of-life, and difficult conversations), (2) additional patient-related communication barriers (eg, hearing problems, delirium), and (3) other considerations related to in-person interpreter expertise (cultural contexts and prebriefing) and barriers to use (eg, delays, difficulty contacting interpreters). Conclusions Acute care clinicians often prefer in-person interpretation owing to factors that are either specific to in-person interpretation or cannot be fully replicated via remote modalities. Acute care clinicians consider conversation complexity, patient factors, and unique benefits versus logistical barriers when considering in-person interpretation. Overall, in-person interpretation provides advantages over alternative modalities for several scenarios to improve the quality of care for patients with non-English language preference in ICUs and acute care settings.
Performance of Large Language Models in Image-Based Evaluation of Dupuytren Contracture
Romero, Matthew , Noland, Shelley

HAND | October 27, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1177/15589447261495085 | PMID 42936939 Get It

Background: Artificial intelligence (AI) has been utilized as a supplemental tool by patients and providers in the evaluation of common hand pathology. This study evaluated the ability of 3 large language model (LLM)-based AI systems (ChatGPT, Gemini, and Claude) to characterize Dupuytren’s contracture involvement and recommend treatment based solely on patient images. Methods: A heterogeneous set of publicly available images was obtained from open-access databases and literature sources. Images were evaluated by LLMs in independent stateless sessions using a standardized prompt to identify contracture characteristics and recommend treatment. Artificial intelligence outputs were compared with consensus assessments from 3 board-certified hand surgeons. Results: Large language models demonstrated limited accuracy in characterizing Dupuytren’s contracture involvement from patient images. Treatment recommendations were often within 1 ordinal tier of surgeon consensus; however, agreement with surgeons was no greater than chance. No consistent differences in performance were observed among the models. Conclusions: Large language model-based AI systems demonstrated limited capability in the image-based assessment and treatment recommendation of Dupuytren’s contracture. These findings highlight a gap between current LLM performance and surgeon consensus when evaluating Dupuytren’s contracture from single-patient-submitted images. Further research is needed to determine whether the incorporation of standardized clinical information can improve the reliability of AI-assisted treatment recommendations.
Efficacy and Safety of Pharmacologic Therapies in Nonobstructive Hypertrophic Cardiomyopathy: A Systematic Review
Patel, Shivam , Gandhi, Akash , Pabani, Arman , Shah, Richa , Shah, Pal , Martinez, Matthew W , Bavishi, Aakash

Journal of the American Heart Association | October 23, 2026 | Volume: 15 | Issue: 21 | Pages: No page available

10.1161/jaha.126.051256 | PMID 42924841 Get It

Background Nonobstructive hypertrophic cardiomyopathy (HCM) affects approximately one‐third of all patients with HCM and carries substantial morbidity, yet no approved disease‐modifying therapies exist. We conducted a systematic review of prospective interventional studies evaluating pharmacologic therapies in adults with nonobstructive HCM. Methods A systematic search of PubMed, Cochrane Central Register of Controlled Trials, and Clinicaltrials.gov was performed through September 2025. Eligible studies included randomized and nonrandomized prospective interventional trials. A narrative synthesis was performed by pharmacologic class and outcome domain. Results Twenty‐nine clinical trials evaluating 9 pharmacologic classes were identified: cardiac myosin inhibitors, cardiac sarcomere modulators, metabolic modulators, angiotensin II receptor blockers, angiotensin receptor‐neprilysin inhibitors, mineralocorticoid receptor antagonists, SGLT2 (sodium‐glucose cotransporter 2) inhibitors, beta blockers, and calcium channel blockers. Cardiac myosin inhibitors demonstrated reductions in left ventricular hypertrophy, improvements in diastolic function, and marked reductions in cardiac biomarkers, although improvements in exercise capacity and symptoms were variable. SGLT2 inhibition showed concordant improvements in diastolic function, atrial remodeling, biomarkers, and functional status in patients with symptomatic nonobstructive HCM and comorbid type 2 diabetes. Angiotensin receptor blockade showed signals of structural remodeling with valsartan and candesartan without consistent functional benefit. Mineralocorticoid receptor antagonism and angiotensin receptor‐neprilysin inhibition demonstrated largely neutral effects. Among metabolic modulators, ninerafaxstat improved ventilatory efficiency and quality of life in patients with greater baseline symptom burden. Conclusions Pharmacologic responsiveness in nonobstructive HCM is variable and appears to be mechanism‐ and disease stage‐dependent. Ongoing trials evaluating cardiac myosin inhibitors, SGLT inhibitors, and novel therapeutic agents including ninerafaxstat and EDG‐7500 will be critical in further defining the therapeutic landscape.
The Clinical Significance of Hyperkinetic Biliary Dyskinesia on HIDA Scan
Elek, Alperen , Bilgin, Gokce Belge , Bilgin, Cem , Bartlett, David, Thorpe, Matthew P , Packard, Annie T , Homb, Andrew C, Lunn, Brendan W

Clinical Nuclear Medicine | October 23, 2026 | Volume: No volume available | Issue: No issue available | Pages: No page available

10.1097/rlu.0000000000006713 | PMID 42912575 Get It

Background: Hyperkinetic biliary dyskinesia, defined as a gallbladder ejection fraction (EF) ≥80% on cholecystokinin (CCK)-stimulated hepatobiliary iminodiacetic acid scans in the setting of biliary-type pain, has been increasingly recognized as a potential functional gallbladder disorder. The clinical significance of this entity and the role of cholecystectomy remain uncertain. Patients and Methods: We conducted a systematic review and meta-analysis of studies reporting outcomes in patients with CCK-hepatobiliary iminodiacetic acid EF ≥80% who underwent cholecystectomy due to non-acute biliary-type pain. Primary outcomes included mean EF, rates of symptom resolution and improvement following cholecystectomy, and prevalence of chronic cholecystitis on pathology. Secondary outcomes included normal histology rates and symptom reproduction with CCK stimulation. All statistical analyses were conducted in R (version 4.5.0) using a random-effects model to obtain pooled estimates. Results: A total of 14 retrospective studies, including 686 patients, were analyzed. The pooled mean gallbladder EF was 90.27% (95% CI: 88.73–91.80, I 2 = 86.6%). Symptom resolution occurred in 83.1% (95% CI: 76.7–89.4, I 2 = 76.8%), and symptom improvement in 91.6% (95% CI: 89.0–94.2, I 2 = 29.7%) of patients following cholecystectomy. Histopathologic analysis revealed chronic cholecystitis in 85.1% (95% CI: 76.9–93.4, I 2 = 90.6%) of surgical specimens, while normal gallbladder histology was rare, observed in only 9.9% (95% CI: 4.6–15.2, I 2 = 83.7%). The pooled risk ratio indicated a 6.70-fold higher likelihood of chronic cholecystitis compared with normal histology (95% CI: 3.69–12.17, I 2 = 65.2%, P = 0.0022). Functional reproduction of symptoms during CCK stimulation was frequent, with a pooled rate of 78.3% (95% CI: 70.4–86.3, I 2 = 35.6%). Egger regression test suggested potential publication bias for the normal histology outcome ( P = 0.0223), but not for symptom resolution ( P = 0.1589). Conclusions: This meta-analysis suggests that a high gallbladder EF in the setting of biliary-type pain could represent clinically relevant hyperkinetic biliary dyskinesia rather than normal physiology. Cholecystectomy appears to provide meaningful symptom relief in appropriately selected patients, and pathologic findings frequently indicate underlying chronic inflammation. Further studies are needed to establish clear diagnostic cutoffs and guide management.